Literature DB >> 30898042

An update on: long-term outcomes of penile prostheses for the treatment of erectile dysfunction.

Brian Dick1, Peter Tsambarlis1, Amit Reddy1, Wayne Jg Hellstrom1.   

Abstract

INTRODUCTION: Penile prosthesis placement is the gold standard for the treatment of erectile dysfunction (ED) refractory to medical therapy; however, limited data exist on the long-term outcomes of these devices. AREAS COVERED: A PubMed search focused on long-term outcomes of penile prosthetics was performed. Studies with a follow-up of less than 5 years were excluded. Included studies were arranged chronologically by implant date to identify trends in device lifetime. Data were further scrutinized to separate device failure secondary to mechanical malfunction from device failure secondary to infection. EXPERT OPINION: Limited data prevent accurate 15-year predictions for modern prosthetics. The 5- and 10-year overall survival of modern prosthetics is estimated to be 90.4% and 86.6%, respectively. Infection rates are estimated to be 1.5% and 1.8% at 8 and 10 years, respectively. While great strides have been made in device design, there is still potential for advancement in both infection rate reduction and mechanical improvement. The combination of increased collaboration between implanting urologists and engineers from prosthetic device companies and improved, prospectively collected data will usher prosthetic urology into its next era.

Entities:  

Keywords:  Penile prosthesis; device survival; erectile dysfunction; outcomes; semirigid device

Mesh:

Year:  2019        PMID: 30898042     DOI: 10.1080/17434440.2019.1598259

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

Review 1.  Future considerations in prosthetic urology.

Authors:  Landon Trost
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

Review 2.  Narrative review of penile prosthetic implant technology and surgical results, including transgender patients.

Authors:  Michael Polchert; Brian Dick; Omer Raheem
Journal:  Transl Androl Urol       Date:  2021-06

Review 3.  Novel Emerging Therapies for Erectile Dysfunction.

Authors:  Soyeun Kim; Min Chul Cho; Sung Yong Cho; Hong Chung; Mahadevan Raj Rajasekaran
Journal:  World J Mens Health       Date:  2020-03-16       Impact factor: 5.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.